Biology Open (BiO) is an Open Access journal that publishes rigorously conducted high-quality research across the breadth of the biological and biomedical sciences. It provides timely, thorough, constructive and fair peer review, with a focus on supporting researchers and reducing the pain to publish.
Our international board of research-active academic Editors, led by Editor-in-Chief Steven Kelly, comprises leaders in their respective fields. The BiO team is committed to Open Access publishing as a mechanism to widen access, promote equality and ensure sustainability in publishing in the biological and biomedical sciences.
BiO included in Read & Publish agreements
From 2022, BiO is included in many of the Read & Publish agreements offered by The Company of Biologists. This enables discounted or fee-free publication of an uncapped number of Research articles in BiO for corresponding authors at participating institutions (including, among others, the Max Planck Digital Library and University of California).
BiO fast-track option
Do you have a paper with reviews from another journal?
BiO editors will fast track your paper and give you an initial decision within one week.
Send us your manuscript together with the full set of reviews and decision letters, and we will make an initial decision in one week (or less).
There is no need to reformat your manuscript.
Future Leader Reviews
Actin cytoskeleton in angiogenesis by Nidhi Yadunandanan Nair, Victor Samuel, Lariza Ramesh, Areeba Marib, Deena T. David and Ananthalakshmy Sundararaman
Sundararaman and colleagues synthesize our current understanding of the roles of actin in vascular morphogenesis, describing how endothelial actin structures and actin-mediated force generation coordinate the multi-step angiogenic process.
The prospect of genetically engineering natural killer cells for cancer immunotherapy by Angie Yu Ching Poon and Ryohichi Sugimura
The authors review recent progress in the use of natural killer (NK) cells for cancer immunotherapy, from the basics of NK cell biology to chimeric antigen receptor-transduced NK cell applications.
Supporting BiO's community of researchers
Latest trends in bioimaging and building a proactive network of early-career young scientists around bioimaging in Europe by Hana Valenta, Nathan Quiblier, Valerio Laghi, Clément Cabriel and Justine Riti
This Meeting Review highlights the latest trends in bioimaging, as discussed at the third Imabio YSN Conference 2022 in Lyon, which was organized by and dedicated to early-career young scientists.
Members of the Euglena International Network describe how euglenoids show great promise to benefit our world, as biofuels, robotics design simulators, cancer treatments and food nutritional agents, but the absence of reference genomes currently limits the realization of these benefits.